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Varicose veins are a worldwide problem. They
affect up to 15% of men and 25% of women and
account for around 56,000 operations each year in
the United Kingdom alone (both the National
Health Service and private health sectors).1,2 Such a
high number of procedures consumes large amounts
of health service resources. The benefit of surgery
for the treatment of varicose veins is understandably
being questioned, because it is not clear how effec-
tive the various forms of treatment are for this con-
dition, the lack of a consistent outcome measure
being a major problem.3,4 With increasing demand
on health service resources, clinicians must justify
the appropriateness and cost-effectiveness of the
treatment they recommend.5 The most comprehen-
sive way to assess the effect of varicose veins on
patients, and whether surgical intervention produces
improvement, is to measure health-related quality of
life (HRQOL).
The Aberdeen Varicose Veins Questionnaire
(Aberdeen Questionnaire) is a disease-specific ques-
tionnaire that measures HRQOL for patients with
varicose veins.6,7 The questionnaire, designed in
1993, consists of 13 questions relating to all aspects
of the problem of varicose veins.6 The questionnaire
has a section in which the patients can indicate dia-
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grammatically the distribution of their varicose
veins. There are questions relating to the amount of
pain experienced, ankle swelling, and use of support
stockings, interference with social and domestic
activities, and the cosmetic aspects of varicose veins.
The questionnaire is scored from zero to 100, where
zero represents a patient with no evidence of vari-
cose veins and 100 represents the most severe prob-
lems associated with varicose veins. In the develop-
ment of this questionnaire, two independent vascu-
lar surgeons weighted the individual questions in
proportion to the perceived contribution to severity
of the question.
This instrument (in this contest, an instrument
describes a questionnaire that assesses HRQOL),
despite having undergone rigorous testing as a mea-
sure of health outcome,6,7 has never been used in clin-
ical practice, and so its responsiveness to the symptoms
and concerns of patients with varicose veins has not
been fully assessed. This instrument gives a single
index for HRQOL for patients with varicose veins.
Specific instruments, such as the Aberdeen Question-
naire, may be more responsive to clinically important
changes in health as a result of an intervention.
Because of their specific nature, they may not take into
account the side effects of a treatment, which is a rea-
son why they are usually used alongside a generic
instrument such as the short-form health survey with
36 items (SF-36). Also specific instruments do not take
into account the influence of comorbidity on the
HRQOL. A copy of the questionnaire and details of its
scoring system can be obtained from the developers of
the instrument and is appended in this article.6
The SF-36 general health survey is a well-vali-
dated generic measure of health status used for mul-
tiple conditions worldwide8-11 including varicose
veins.6,7,12 The SF-36 provides a summary of
HRQOL. It is not specific to any disease or treat-
ment and therefore can take account of multiple
conditions and the influence of comorbidity on
health.8-10 The SF-36 consists of 36 questions form-
ing eight domains of health that fit broadly into
physical or mental health status scales. In contrast to
the Aberdeen Questionnaire, the SF-36 domains are
scored where zero represents the worse possible
health and 100 the best possible health. A license to
use the SF-36 with details of how to score the ques-
tionnaire can be obtained from the Medical
Outcomes Trust.10 To assess fully HRQOL for any
given condition it is preferable to use both a gener-
ic and a specific instrument.10,11 The use of two
measures of health status such as those discussed
above should give a true representation of the prob-
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lem to the patient. These measures should be able to
determine what impact, if any, treatment has on the
problem.
This study aims to validate the Aberdeen
Questionnaire as a measure of health outcome, to
determine the HRQOL in a population of patients
with varicose veins and to see if the surgical correc-
tion of varicose veins on a cohort of patients affects
their quality of life.
PATIENTS AND METHODS
Selection and data collection. A prospective
consecutive cohort of National Health Service
patients with clinically obvious primary varicose
veins without venous ulceration awaiting surgery
were recruited into the study over a period of 14
months. This included 137 patients, of whom 71%
were women with a median age of 46 years (range,
22–82 years, 11 patients over the age of 65 years).
One hundred nine patients were available for follow-
up at 6 weeks (response rate, 80%).
It is difficult for the clinician to be sure why a
particular patient will seek surgery for varicose veins,
because they may not tell the whole truth. However,
we included consecutive patients with clinically
obvious varicose veins with proven incompetence on
Doppler/duplex scans of the long or short saphe-
nous systems who said they had pain or whose vari-
cose veins troubled them. A previous audit of our
varicose vein surgery has shown that the main com-
plaint, in approximately 20% of patients, was the
appearance of the veins. Specific exclusions included
patients with recurrent varicose veins, ulcers, or deep
venous disease. All patients were asked to complete
a self-administered questionnaire booklet that
included the SF-36, the Aberdeen Questionnaire,
and a set of 25 questions focusing on the symptoms
and concerns of patients with varicose veins (see
below). Only two patients refused entry into the
study when approached. All patients underwent a
planned operation as detailed below. Eighty-five
patients underwent surgery of the long saphenous
system alone involving flush sapheno-femoral trans-
fixion and stripping of the long saphenous vein to
just below the knee. Nine patients had short saphe-
nous vein surgery alone involving sapheno-popliteal
junction transfixion and removal of at least 5 cm of
short saphenous vein. The remainder (15 patients)
had both long and short saphenous vein surgery. All
patients underwent stab phlebectomies of visible
varicose veins with the use of either the Oesch hooks
or a Kocherized mosquito clip. Forty-six percent of
the patients in this study had bilateral surgery. All
patients were then evaluated 6 weeks later in the
outpatient department. At this point, they were
assessed clinically and asked to complete a second
questionnaire booklet containing the SF-36 and the
Aberdeen Questionnaire. All data were analyzed by
using SPSS (Statistical Package for the Social
Sciences) software (SPSS Inc., Chicago, Ill). Ethics
committee approval was obtained for this study.
Validation of the Aberdeen Questionnaire.
For an instrument to be used as a measure of health
outcome, it needs to be reliable, valid, responsive,
and practical.9,10 All these aspects were assessed for
the Aberdeen Questionnaire. Reliability in the con-
text of health outcome measurement is the ability of
the instrument to measure its subject consistently.
Reliability was assessed with a test of internal consis-
tency, Cronbach’s alpha. This test assesses the aver-
age level of correlation between items comprising a
scale. If the instrument is measuring a single con-
struct (all items in the questionnaire are focused on
a specific problem), then there should be a high level
of concordance between these items. If an instru-
ment is to be reliable, alpha should exceed 0.7.13
Test-retest analysis has previously been performed
on this instrument,7 and it has shown stability over
time. Validity in this context is the ability of the
instrument to measure what is intended. This was
assessed by correlation between the scores obtained
for the Aberdeen Questionnaire with those obtained
for the patient symptoms and concerns question-
naire and the SF-36 survey as the “gold-standard” in
HRQOL assessment. Responsiveness in this context
is the ability of the instrument to detect important
changes in health and was assessed by using the stan-
dardized response means (SRM). One would expect
an improvement in the scores for the Aberdeen
Questionnaire after the postoperative period of
recovery after varicose vein surgery, which would be
represented by the SRM. The SRM is the mean
change in score for a scale divided by the standard
deviation of the change.14 An SRM of greater than
or equal to 0.2, 0.5, and 0.8 indicate small, moder-
ate, and large clinical changes, respectively.14 This
standardized method allows comparisons to be
made between different instruments. Lastly, practi-
cality was assessed by determining the time taken to
complete the questionnaires, how “complete” the
questionnaires were, how acceptable they were to
the patients, and how easy the questionnaires were
to administer.
Patient symptoms and concerns question-
naire. As mentioned, the Aberdeen Questionnaire
has yet to be used in clinical practice. Therefore, the
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patients were given another questionnaire to ensure
the Aberdeen Questionnaire was tapping those
aspects of health important to a patient with varicose
veins in terms of the patient’s symptoms and con-
cerns. This questionnaire was designed in the way
recommended by Streiner and Norman15 through a
process of patient interview, literature search, and
expert opinion. Twenty patients with varicose veins
underwent taped interviews of 10 to 20 minutes’
duration with a series of open and closed questions
regarding the problems they had with their veins. A
literature search was performed to determine what
the perceived problems are for a patient with vari-
cose veins. Lastly, three vascular surgeons were inter-
viewed to see what they perceived as the main prob-
lems a patient with varicose veins will have.
From these three sources, a bank of 25 questions
was compiled and arranged randomly on the ques-
tionnaire. The questions were posed in such a way so
the patients were first asked about the presence of the
particular problem. If the patients answered yes, they
were then asked to grade the severity of this problem
on a scale of 1 to 5, with 1 reserved for “no impor-
tance” and 5 for “very important.” A score was cal-
culated for each questionnaire based purely on the
severity score attributed to each problem by the
patients. This score was then rescaled to give a mark
of zero to 100, where zero was reserved for no prob-
lems and 100 for the worst possible problems. The 25
questions used are appended with this article.
RESULTS
The results follow in three sections: validation of
the Aberdeen Questionnaire, HRQOL determina-
tion of the study population, and effect of surgery
on HRQOL.
Validation of Aberdeen Questionnaire
Reliability. Cronbach’s alpha for the Aberdeen
Questionnaire was 0.74. Alpha values for each of the
eight domains of the SF-36 were also all above 0.7,
as shown in Table I.
Validity. A score was calculated for the Aberdeen
Questionnaire in the way recommended by the instru-
ments’ developers as described above. A score was also
calculated for the “patient’s concerns questionnaire”
that was based on the presence of and importance of
the symptoms and concerns of patients with varicose
veins as described above. An association was then
sought between these two separate scores, and the
results can be seen in the scatter plot shown in Fig 1.
A highly significant strong association, by using
Pearson’s correlation coefficient, was found between
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the two scores r = 0.74, P < .001 (95% confidence
intervals = 0.63 to 0.80). A significant association, by
Spearman’s correlation coefficient, was found between
the Aberdeen Questionnaire scores and four domains
of the SF-36: “Physical Functioning,” “Pain,” “Role
Limitation due to Physical Problems,” and “Social
Functioning” (Table II). Of particular note, 3 of the 4
significant correlations were in those domains measur-
ing “physical health,” for example, a correlation of 0.4,
P < .01, (95% confidence intervals = 0.63-0.80) was
obtained between the Aberdeen Questionnaire and
the domain of “Physical Functioning” in the SF-36.
Responsiveness. The SRM was calculated from
the Aberdeen Questionnaire scores at 6 weeks, and
a value of 0.55 was obtained.
Practicality. Practicality of the instrument has
been demonstrated in a number of ways: (1) It takes
less than 5 minutes to complete. (2) Of 109 com-
pleted questionnaires at 6 weeks, only 1 had to be
rejected from the analysis because less than 50% of
questions were completed. (3) The questionnaire is
simple to administer to patients from the clinicians
point of view because they are contained in one
booklet and are completed without physician input.
Comparison with the general population
To assess the impact of varicose veins on
HRQOL, we took the scores obtained on the SF-36
for the study population and compared them with
those obtained for the general population, using a
Mann-Whitney U test (Fig 2). The general popula-
tion scores were from a sample of more than 9000
patients in the United Kingdom (age range, 18-64
years)16 (personal communication with Dr Crispin
Jenkinson, Department of Public Health and
Primary Care, University of Oxford). Men and
women were analyzed separately. For the study pop-
ulation, women scored on average less (meaning
worse function/health) than the UK norms for all
eight domains of the SF-36, this difference being
significant in four of the eight domains. Men also
scored less (worse function/health) than UK norms
for six of the eight domains, this difference being
significant in two of the eight domains. In the two
domains (energy and mental health) where the men
scored more than UK norms, the difference was not
significant. In both men and women this difference
in scores was most noticeable in the domains assess-
ing physical, rather than mental, health problems.
Table I. Cronbach’s alpha values for the eight
domains of the SF-36
Domain Cronbach’s alpha value
PF 0.86
RP 0.84
BP 0.76
GH 0.75
VT 0.85
SF 0.74
RE 0.87
MH 0.82
PF, Physical functioning; RP, role limitation due to physical prob-
lems; BP, bodily pain; GH, general health; VT, energy; SF, social
functioning; RE, role limitationdue to emotional problems; MH,
mental health. Fig 1. Relationship between the score for the patients’
“symptoms and concerns questionnaire” and the
Aberdeen Questionnaire. AVVQ, Aberdeen Varicose Veins
Questionnaire. (r = 0.74, P < .001, 95% confidence inter-
vals = 0.63 to 0.80.)
Table II. Relationship between the scores for the
Aberdeen Questionnaire and the eight domains of
the SF-36
Correlation Coefficient 95% confidence
Domain (Spearman) intervals
PF –0.394* –0.53 to –0.24
RP –0.409* –0.55 to –0.25
BP –0.391* –0.53 to –0.23
GH –0.178 –0.34 to –0.01
VT –0.161 –0.33 to 0.01
SF –0.390* –0.53 to –0.23
RE –0.169 –0.33 to 0
MH –0.175 –0.34 to –0.01
Asterisk, P < .01; CIs, confidence intervals; PF, physical function-
ing; RP, role limitation due to physical problems; BP, bodily pain;
GH, general health; VT, energy; SF, social functioning; RE, role
limitation due to emotional problems; MH, mental health.
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The effect of surgery
After surgery, the SF-36 scores increased (improve-
ment in function) in all eight domains of health, reach-
ing significance in “Mental Health” (P < .05) and
approaching significance in “General Health” (P =
.066; Fig 3; Wilcoxon signed rank sum test). The
scores obtained from the Aberdeen Questionnaire
(Table III) indicated that there was a highly significant
improvement in HRQOL (P < .001). Question 2 of
the SF-36 is not used when forming any of the eight
domains of health and is known as the “health tran-
sition item.” The question asks, “Compared to one
year ago, how would you rate your health in general
now?” on a 5-point scale, ranging from “Much bet-
ter than one year ago” to “Much worse than one year
ago.” There are two versions of the SF-36 in use, the
“acute” 1-week version and the standard 4-week ver-
sion.10 These versions have the wording of the ques-
tions changed appropriately depending on the period
chosen. The version used in this study was the 4-
week standard version. Question 2 was reworded to
read “Compared to before your operation....” None
of the other questions had the wording changed, and
therefore do not invalidate the scoring of the ques-
tionnaire.
Table III describes the scores obtained at 6 weeks
for both the Aberdeen Questionnaire and question 2
of the SF-36. As with the Aberdeen Questionnaire
scores, there is a highly significant improvement in
health 6 weeks after surgery (P < .001).
DISCUSSION
Varicose vein surgery in the National Health
Service is an obvious target for exclusion to reduce
costs, as some may see this surgery as not essential.
Table III. Change in scores of question 2 of the
SF-36 and the Aberdeen Questionnaire after surgery
Pre-op Post-op P value
Aberdeen Questionnaire 18.82 14.08 < .0001
Question 2 SF-36 50.68 64.38 < .0001
Fig 3. Change in scores for the eight domains of the SF-
36, 6 weeks after surgery (all patients). Asterisk, P = .66;
double asterisk, P < .05; PF, physical functioning; RP, role
limitation due to physical problems; BP, bodily pain; GH,
general health; VT, energy; SF, social functioning; RE, role
limitation due to emotional problems; MH, mental health.
Fig 2. A, Comparison of the eight domains of the SF-36
for the study population and UK norms (men). B,
Comparison of the eight domains of the SF-36 for the
study population and UK norms (women). Asterisk, P <
.01; double asterisk, P < .001; PF, physical functioning;
RP, role limitation due to physical problems; BP, bodily
pain; GH, general health; VT, energy; SF, social function-
ing; RE, role limitation due to emotional problems; MH,
mental health.
A
B
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This is especially so if there is a predominantly cos-
metic aspect to the patient’s complaints. Some
health authorities wish to curtail treatment for vari-
cose veins17 as a cost-reduction exercise.
It can be difficult to get “honest” answers from
patients regarding the severity of their symptoms
and thus “honest” answers to the questionnaires.
One would assume that some patients will “fake-
bad”15 and answer the questionnaires in such a way
as to give the worst response in order to maximize
their chances of obtaining an intervention for their
condition. This effect is difficult to prevent, but it
was minimized here by getting the patients to com-
plete their questionnaires immediately before
surgery, by which time there is little point in “fak-
ing-bad.”
The Aberdeen Questionnaire is reliable and com-
pares well to the results obtained by the instrument’s
developers.6,7 The significant association found
between the Aberdeen Questionnaire and the SF-36
is strong evidence of its validity as a measure of
HRQOL. The highly significant association of the
Aberdeen Questionnaire with the patients’ symptoms
and concerns questionnaire further strengthens this.
The four domains of the SF-36 that had a high corre-
lation with the Aberdeen Questionnaire (“Pain,”
“Social Functioning,” “Physical Functioning,” and
“Role Limitation due to Physical Problems”) are fur-
ther evidence of validity because these are the aspects
of health that you would expect to be affected in a
patient with varicose veins. The instrument is respon-
sive, as shown by an SRM of 0.55. This indicates a
moderate sensitivity to clinical change—SRMs of
greater than or equal 0.2, 0.5, and 0.8 indicating
changes of small, moderate, and large clinical changes,
respectively.14 The Aberdeen Questionnaire therefore
fulfilled all four attributes necessary for an instrument
to be used as a measure of health outcome and
HRQOL. However, the restrictive nature of specific
instruments can limit their ability to capture the side
effects of an intervention that a responsive general
health profile should detect. This problem should be
avoided if the instrument was designed correctly and
if it is used in conjunction with a generic instrument.
A quality-of-life instrument was developed for all
forms of venous disease and published in Vasa,18 the
Freiburger Questionnaire of Quality of Life in Venous
Diseases. This instrument would not have been suit-
able for this study for several reasons. First, and most
important, to measure quality of life accurately a spe-
cific measure of quality of life must be used in con-
junction with a generic measure. The Freiburger
questionnaire assesses all grades of venous disease
from normal legs to those with venous ulcers and
therefore, by definition, is not specific. Furthermore,
the Nottingham Health Profile was used to determine
validity for this instrument. It is recognized that the
Nottingham Health Profile has limitations as a gener-
ic quality-of-life measure and the SF-36 is recom-
mended as being a superior measure.11
It also emerges that when the SF-36 is used to
assess patients with varicose veins, they have a
reduced quality of life compared with the general
population in both men and women. This reduction
is more clearly seen in the physical health domains
than the emotional health domains and was a signif-
icant reduction in four of the eight domains for
women and in two of the eight domains for men
(Fig 2). Patients request surgery for a number of
reasons, and whatever these reasons are, the patients
have a reduced quality of life compared with the
general population. Use of the SF-36 to assess
patients with varicose veins has shown that if vari-
cose veins trouble a patient then there is a significant
physical component. This deleterious effect of vari-
cose veins on health has been measured in the
past,6,7 but it is slightly different to the findings of
Baker et al,12 who found that the deleterious effect
was seen only in the domains of “pain” and “gener-
al health.”
A follow-up rate of 80% was achieved at 6 weeks.
This is a little disappointing because great effort was
undertaken to obtain a higher rate. One can only
speculate on the reasons for the 20% who did not
attend. A small proportion will be lost due to holi-
days and house moves and so on, but it is more like-
ly that those patients who did not attend saw no
good reason to attend—because they were well with
no further problems. This does not explain, howev-
er, why they did not return the questionnaires post-
ed out to them.
Although the improvement in health by opera-
tion as measured by the SF-36 reached significance
in one domain (“Mental Health”) and approached
significance in one other domain (“General
Health”), it may be too early at 6 weeks to see the
full effect of surgery, and the patients are therefore
being followed up for 1 year. Furthermore, the sam-
ple size required to see a significant change in all
domains is large. The size varies considerably across
the SF-36 scales and across study designs.10 The
three scales of “Vitality,” “General Health,” and
“Mental Health” do best in this regard. A 5-point
change in scores defines differences that are clinical-
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ly and socially relevant,10 and for the above study
design sample sizes of 139, 132, and 104, respec-
tively, are required to reach a power of 80% with sig-
nificance at the 5% level.10 Others have shown a
reduction in some of the health domains at 4 weeks
after surgery.12 Despite this, patients did perceive
their general health to be significantly improved
after surgery, as measured by question 2 of the SF-
36. This improvement in health was clearly demon-
strated with the Aberdeen Questionnaire. This may
be due to its more restricted focus, which makes it
more responsive to small but important changes in
health.
If surgery for varicose veins is denied on the
National Health Service, patients will continue to
complain and consume resources elsewhere through
their ongoing dissatisfaction. It could be that vari-
cose vein surgery on the National Health Service is
not only best for the patient but relieves primary
care of an otherwise mounting problem.
CONCLUSION
This study has demonstrated that the presence of
varicose veins significantly affects patients’ quality of
life. The Aberdeen Questionnaire is a valid specific
measure of HRQOL; when it is used with the gener-
ic SF-36, the full effect of varicose veins on patients’
quality of life can be measured. Surgery for varicose
veins does significantly improve patients’ HRQOL
even at 6 weeks.
We thank Dr Crispin Jenkinson of the Health Services
Research Unit, University of Oxford for the UK SF-36
normative data.
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APPENDIX 1. THE ABERDEEN VARICOSE VEINS QUESTIONNAIRE
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APPENDIX 2. THE “PATIENTS SYMPTOMS AND CONCERNS” QUESTIONNAIRE
Do you have Not Very
this problem important important
• Itching Y/N 1 2 3 4 5
• Swelling of ankles/legs Y/N 1 2 3 4 5
• Does the appearance of your veins Y/N 1 2 3 4 5
worry you?
• Skin discoloration Y/N 1 2 3 4 5
• Aching Y/N 1 2 3 4 5
• Skin rash/eczema Y/N 1 2 3 4 5
• Night cramps Y/N 1 2 3 4 5
• Phlebitis (tender, red, hard painful veins) Y/N 1 2 3 4 5
• Pain Y/N 1 2 3 4 5
• Anxiety about veins getting worse Y/N 1 2 3 4 5
• Limitation of daily activities Y/N 1 2 3 4 5
Which activities? :work Y/N 1 2 3 4 5
:study Y/N 1 2 3 4 5
:housework Y/N 1 2 3 4 5
:walking Y/N 1 2 3 4 5
:other (please state...................) 1 2 3 4 5
• Limitation of leisure activities Y/N 1 2 3 4 5
Which activities? :sport Y/N 1 2 3 4 5
:hobbies Y/N 1 2 3 4 5
:social life Y/N 1 2 3 4 5
:other (please state...................) 1 2 3 4 5
• Does the appearance of your veins limit Y/N 1 2 3 4 5
your activities?
please ring which activity:  (work, sport, leisure, other............................)
(if other please state)
• Anxiety about ulcers developing Y/N 1 2 3 4 5
• Does the appearance of your veins limit Y/N 1 2 3 4 5
your choice of clothes?
• Do your veins give you trouble at rest? Y/N 1 2 3 4 5
